Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients

European Journal of Health Economics

Volumn 12, Issue 5, 2011, Pages 489-497

  Sabariego, C ^a   Brach, M ^a,b   Herschbach, P ^c   Berg, P ^c   Stucki, G ^b,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b SWISS PARAPLEGIC RESEARCH   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF LUCERNE   (Switzerland)

Author keywords

Cancer; Cognitive behavioral therapy; Cost effectiveness; Economic evaluation; Resource use

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; FEAR; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; FEAR; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 80655135608     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-010-0266-y     Document Type: Article

References (30)

1. Hoffman, D.L., Dukes, E.M., Wittchen, H.U.: Human and economic burden of generalized anxiety disorder. Depress Anxiety, 1091-4269 (2006)
2. Andlin-Sobocki, P., Wittchen, H.U.: Cost of anxiety disorders in Europe. Eur. J. Neurol. 12(Suppl 1), 39-44 (2005) (Pubitemid 40755602)
3. Wittchen, H.U.: Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety 16, 162-171 (2002)
4. Herschbach, P., Berg, P., Dankert, A., Duran, G., Engst-Hastreiter, U., Waadt, S., Keller, M., Ukat, R., Henrich, G.: Fear of progression in chronic diseases: psychometric properties of the fear of progression questionnaire. J. Psychsom. Res. 58, 505-511 (2005) (Pubitemid 41206846)
5. Sheard, T., Maguire, P.: The effect of psychological interventions on anxiety and depression in cancer patients: results of two metaanalyses. Br. J. Cancer 80, 1770-1780 (1999) (Pubitemid 29389631)
6. Meyer, T.J., Mark, M.M.: Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol. 14, 101-108 (1995)
7. Newell, S.A., Sanson-Fisher, R.W., Savolainen, N.J.: Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J. Natl Cancer Inst. 94, 558-584 (2002) (Pubitemid 34498644)
8. Owen, J.E., Klapow, J.C., Hicken, B., Tucker, D.C.: Psychosocial interventions for cancer: review and analysis using a three-tiered outcomes model. Psychooncology 10, 218-230 (2001) (Pubitemid 32466047)
9. Herschbach, P., Berg, P., Waadt, S., Duran, G., Engst-Hastreiter, U., Henrich, G., Book, K., Dinkel, A.: Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother. Psychosom. 79, 31-38 (2010)
10. Herschbach, P., Book, K., Dinkel, A., Berg, P., Waadt, S., Duran, G., Engst-Hastreiter, U., Henrich, G.: Evaluation of two group therapies to reduce fear of progression in cancer patients. Support. Care Cancer 18, 471-479 (2010)
11. Rosenberg, H.J., Rosenberg, S.D., Ernstoff, M.S., Wolford, G.L., Amdur, R.J., Elshamy, M.R., Bauer-Wu, S.M., Ahles, T.A., Pennebaker, J.W.: Expressive disclosure and health outcomes in a prostate cancer population. Int. J. Psychiatry Med. 32, 37-53 (2002) (Pubitemid 34606525)
12. Simpson, J.S., Carlson, L.E., Trew, M.E.: Effect of group therapy for breast cancer on healthcare utilization. Cancer Pract. 9, 19-26 (2001) (Pubitemid 32106699)
13. Mehnert, A., Herschbach, P., Berg, P., Henrich, G., Koch, U.: Fear of progression in breast cancer patients - validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF). Z. Psychosom. Med. Psychother. 52, 274-288 (2006) (Pubitemid 44469869)
14. Herschbach, P., Duran, G., Engst-Rastreiter, U., Waadt, S., Berg, P.: Gruppentherapetische Behandlung von Progredienzangst bei Krebspatienten. Verhaltenstherapie Verhaltensmedizin 27, 298-309 (2006)
15. Hessel, F., Wittman, M., Petro, W., Wasem, J.: Methoden zur Kostenerfassungim Rahmen der ökonomischen Evaluation einer Rehabilitations-maßnahme bei chronischen Atemwegserkrankungen. Pneumologie 54, 289-295 (2002) (Pubitemid 30604007)
16. Rote-Liste: Rote Liste Service GmbH. In: ECV Verlag, Frankfurt (2004)
17. AOK: Vergütungsliste für Orthopädische Hilfsmittel der Prima ̈rkassen in Bayern (2004)
18. Krauth, C., Hessel, F., Hansmeier, T., Wasem, J., Seitz, R., Schweikert, B.: Empirical standard costs for health economic evaluation in Germany - a proposal by the working group methods in health economic evaluation. Gesundheitswesen 67, 736-746 (2005) (Pubitemid 41604934)
19. Gandek, B., Ware, J.E., Aaronson, N.K., Apolone, G., Bjorner, J.B., Brazier, J.E., Bullinger, M., Kaasa, S., Leplege, A., Prieto, L., Sullivan, M.: Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. International quality of life assessment. J. Clin. Epidemiol. 51, 1171-1178 (1998) (Pubitemid 28527173)
20. Barber, J.A., Thompson, S.G.: Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat. Med. 19, 3219-3236 (2000)
21. Carpenter, J., Bithell, J.: Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat. Med. 19, 1141-1164 (2000) (Pubitemid 30265928)
22. Drummond, M.F., O'Brien, B., Stoddart, G.L., Torrance, G.W.: Methods for the Economic Evaluation of Health Care Programmes, 2nd edn. Oxford Medical Publications, New York (1997)
23. Briggs, A.H.: Statistical approaches to handling uncertainty in health economic evaluation. Eur. J. Gastroenterol. Hepatol. 16, 551-561 (2004) (Pubitemid 38703863)
24. Chiles, J.A., Lambert, M.J., Michael, J., Hatch Arlin, L.: The impact of psychological interventions on medical cost offset: a meta-analytic review. Clin. Psychol. Sci. Prax. 6, 204-220 (1999)
25. Knapp, M., Thorgrimsen, L., Patel, A., Spector, A., Hallam, A., Woods, B., Orrell, M.: Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br. J. Psychiatry 188, 574-580 (2006) (Pubitemid 43844106)
26. Briggs, A.: Economic evaluation and clinical trials: size matters. BMJ 321, 1362-1363 (2000)
27. Briggs, A., Fenn, P.: Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ. 7, 723-740 (1998) (Pubitemid 29012095)
28. Fenwick, E., O'Brien, B.J., Briggs, A.: Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ. 13, 405-415 (2004) (Pubitemid 38660390)
29. Heuzenroeder, L., Donnelly, M., Haby, M.M., Mihalopoulos, C., Rossell, R., Carter, R., Andrews, G., Vos, T.: Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Aust. N. Z. J. Psychiatry 38, 602-612 (2004) (Pubitemid 39199487)
30. Chuang, L.H., Kind, P.: Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies. Pharmacoeconomics 27, 491-505 (2009)